Abstract
We examined scratch-inducing effects of intracisternal, intrathecal and intradermal injections of morphine and some opioid agonists in mice. Intracisternal injection of morphine (3 nmol/animal) and the μ-receptor agonist [D-Ala2, N-Me-Phe4, Gly5-ol]enkephalin (DAMGO; 0.2 nmol/animal) elicited scratching of the face, with little effect on scratching of the trunk. Intracisternal injection of the δ-receptor agonist [D-Pen2,5]enkephalin (DPDPE) and the κ-receptor agonist U50488 were without effects. Intrathecal injection of morphine (0.1–3 nmol/animal) produced a dose-dependent increase in body scratching, with little effects on face scratching. Face scratching induced by intrathecal morphine (3 nmol/animal) was almost abolished by subcutaneous pretreatment with naloxone (1 mg/kg). Intradermal injections of morphine (3–100 nmol/site), DAMGO (1–100 nmol/site), DPDPE (10 and 100 nmol/site) and U50488 (10–100 nmol/site) did not elicit scratching of the site of injection. Intradermal injection of histamine (100 nmol/site) induced the scratching in ICR, but not ddY, mice and serotonin (30 and 50 nmol/site) elicited the scratching in either strain of mice. The results suggest that opioids induce scratching, and probably itching, through central μ-opioid receptors in the mouse.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abboud TK, Shnider SM, Dailey PA, Raya JA, Sarkis F, Grobler NM, Sadri S, Khoo SS, DeSousa B, Baysinger CL, et al. Intrathecal administration of hyperbaric morphine for the relief of pain in labour. Br J Anaesth 56:1351–1360;1984.
Andoh T, Nagasawa T, Satoh M, Kuraishi Y. Substance P induction of itch-associated response mediated by cutanoues NK1 tachykinin receptors in mice. J Pharmacol Exp Ther 286;1140–1145;1998.
Ballantyne JC, Loach AB, Carr DB. Itching after epidural and spinal opiates. Pain 33:149–160;1988.
Benyon RC, Lowman MA, Church MK. Human skin mast cells: Their dispersion, purification, and secretory characterization. J Immunol 138:861–867;1987.
Bergasa NV, Alling DW, Talbot TL, Swain MG, Yurdaydin C, Turner ML, Walker EC, Jones EA. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med 123:161–167;1995.
Bernstein JE. Butorphanol-induced pruritus antagonized by naloxone. J Am Acad Dermatol 5:227–228;1981.
Bernstein JE, Swift R. Relief of intractable pruritus with naloxone. Arch Dermatol 115:1366–1367;1979.
Bernstein JE, Swift RM, Soltani K, Lorincz AL. Antipruritic effect of an opiate antagonist, naloxone hydrochloride. J Invest Dermatol 78:82–83;1982.
Ellis HV, Johnson AR, Moran NC. Selective release of histamine from rat mast cells by several drugs. J Pharmacol Exp Ther 175:627–631;1970.
Fjellner B, Hagermark. Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK 33–824, β-endorphin and morphine. Arch Dermatol Res 274:29–37;1982.
Frenk H, Bossut D, Urca G, Mayer DJ. Is substance P a primary afferent neurotransmitter for nociceptive input? I. Analysis of pain-related behaviors resulting from intrathecal administration of substance P and 6 excitatory compounds. Brain Res 455:223–231;1988.
Jones EA, Bergasa NV. The pruritus of cholestasis: From bile acids to opiate agonists. Hepatology 11:884–887;1990.
Koenigstein H. Experimental study of itch stimuli in animals. Arch Dermatol Syphilol 57:828–849;1948.
Kuraishi Y, Nagasawa T, Hayashi K, Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 275:229–233;1995.
Lowman MA, Rees PH, Benyon RC, Church MK. Human mast cell heterogeneity: Histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 81:590–597;1988.
McMahon SB, Koltzenburg M. Itching for an explanation. Trends Neurosci 15:497–501;1992.
Monroe EW. Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis. J Am Acad Dermatol 21:135–136;1989.
Saiah M, Borgeat A, Wilder-Smith OHG, Rifat K, Suter PM. Epidural-morphine-induced pruritus: Propofol versus naloxone. Anesth Analg 78:1110–1113;1994.
Sakurada T, Wako K, Sakurada C, Manome Y, Tan-No K, Sakurada S, Kisara K. Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: Possible involvement of substance P in the mouse spinal cord. Brain Res 724:213–221;1996.
Scott PV, Bowen FE, Cartwright P, Rao BC, Deeley D, Wotherspoon HG, Sumrein IM. Intrathecal morphine as sole analgesic during labour. Br Med J 281:351–355;1980.
Thomas DA, Williams GM, Iwata K, Kenshalo DR Jr, Dubner R. Effects of central administration of opioids on facial scratching in monkeys. Brain Res 585:315–317;1992.
Thomas DA, Hammond DL. Microinjection of morphine into the rat medullary dorsal horn produces a dose-dependent increase in facial scratching. Brain Res 695:267–270;1995.
Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. Br Med J 297:1501–1504;1988.
Tohda C, Yamaguchi T, Kuraishi Y. Intracisternal injection of opioids induces itch-associated response through μ-opioid receptors in mice. Jpn J Pharmacol 74:74–77;1997.
Yaksh TL, Harty GJ, Onofrio BM. High doses of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: Clinical and theoretic implications. Anesthesiology 64:590–597;1986.
Yamaguchi T, Nagasawa T, Satoh M, Kuraishi Y. Itch-associated response induced by intradermal serotonin through 5-HT2 receptors in mice. Neurosci Res 35:77–83;1999.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuraishi, Y., Yamaguchi, T. & Miyamoto, T. Itch-scratch responses induced by opioids through central Mu opioid receptors in mice. J Biomed Sci 7, 248–252 (2000). https://doi.org/10.1007/BF02255473
Issue Date:
DOI: https://doi.org/10.1007/BF02255473